Company & Sponsor Intelligence
Wave Neuroscience
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials4
Recruiting0
Completed4
Countries1
Therapeutic footprint
autismdepressionptsd
Indexed studies
NCT02746445A Longitudinal Study on the Safety and Efficacy for Subjects With ASD Who Received MeRT
autism · United StatesCOMPLETED
autism · United StatesCOMPLETED
NCT03288714Adaptive Design Study of NEST sTMS in Subjects With Major Depressive Disorder
depression · United StatesNA
depression · United StatesNA
NCT01370733Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
depression · United StatesPHASE3
depression · United StatesPHASE3
NCT02990793Clinical Trial to Evaluate the Safety and Efficacy of MeRT Treatment in Post-Traumatic Stress Disorder
ptsd · United StatesNA
ptsd · United StatesNA
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →